Marmora, NJ, United States of America

Matthew Sean Palombo


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Matthew Sean Palombo

Introduction: Matthew Sean Palombo, an accomplished inventor based in Marmora, New Jersey, holds three patents that reflect his innovative contributions to the field of biotechnology. His work focuses on the development of advanced materials and delivery systems that harness the power of polyethylene glycol and peptides, paving the way for new therapeutic applications.

Latest Patents: Among his most recent patents, Palombo has developed novel polyethylene glycol-based dendrons, commonly referred to as PEGtide dendrons. This invention relates to compositions and methods of use, providing valuable insights into the capabilities of dendron-based materials. Additionally, he has created innovative nanocarrier compositions and methods aimed at enhancing the in vivo delivery of bioactive agents. This invention comprises multimeric nanocarriers, featuring at least two linked peptide monomers and bioactive agents, which are covalently bonded through biodegradable moieties.

Career Highlights: Matthew Sean Palombo is associated with Rutgers, The State University of New Jersey, where he collaborates with fellow researchers to push the boundaries of biomaterials research. His commitment to innovation is evident in his multiple patents, which demonstrate his expertise and dedication in developing technologies that have real-world applications.

Collaborations: In his pursuit of pioneering research, Palombo collaborates with notable colleagues such as Patrick J. Sinko and Xiaoping Zhang. Their combined efforts are instrumental in advancing their shared vision of delivering effective and novel solutions in healthcare through biotechnology.

Conclusion: Matthew Sean Palombo's inventive spirit and significant contributions mark him as a noteworthy figure in the realm of biotechnology. His patents—particularly those centered around polyethylene glycol-based dendrons and advanced nanocarrier systems—showcase the potential for innovative technologies to transform therapeutic delivery methods. As he continues his research at Rutgers, we can expect further advancements that will undoubtedly benefit the field and society at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…